Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics

Sexually Transmitted Diseases

Volumn 28, Issue 2, 2001, Pages 99-104

  Whittington, William L H ^a,b   Celum, Connie L ^a,b   Cent, Anne ^a   Ashley, Rhoda L ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN; VIRUS ANTIBODY;

ADULT; AGE; ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT DEPARTMENT; RACE DIFFERENCE; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STANDARD; WESTERN BLOTTING;

EID: 0035121749     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200102000-00007     Document Type: Article

References (20)

1. Herpes simplex virus type 2 in the United States, 1976 to 1994
2. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection
3. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons
4. Risk factors for the sexual transmission of genital herpes
5. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts
6. Acyclovir therapy for genital herpes: Enthusiasm and caution in equal doses
7. Raising the consciousness for identifying and controlling viral STDs: Fears and frustrations
8. Predicting and preventing the emergence of antiviral drug resistance in HSV-2
9. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir
10. The practical application of serological testing for HSV infection
11. Patient attitudes to type specific serological tests in the diagnosis of genital herpes
12. Type-specific antibodies to HSV-1 and-2: Review of methodology
13. Premarket evaluation of a commercial glycoprotein G-based enzyme immuno-assay for herpes simplex virus type-specific antibodies
14. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 & 2 in human sera
15. The acquisition of herpes simplex virus during pregnancy
16. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men
17. Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load
18. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1 infected men
19. Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS